▪ The American Association for Cancer Research recognized eight researchers for their contributions to basic and clinical cancer research.
• Mario R. Capecchi, Ph.D., of the University of Utah School of Medicine in Salt Lake City, received the 6th Pezcoller Foundation-AACR International Award for Cancer Research.
• Ronald A. DePinho, M.D., of Harvard Medical School and the Dana-Farber Cancer Institute in Boston, received the 43rd AACR-G.H.A. Clowes Memorial Award.
• Carlos L. Arteaga, M.D., director of the Vanderbilt-Ingram Cancer Center Breast Cancer Program at Vanderbilt University School of Medicine, Nashville, Tenn., received the 27th AACR-Richard & Hinda Rosenthal Foundation Award.
• Malcolm F. Stevens, Ph.D., Sc.D., of the University of Nottingham in the United Kingdom, received the 22nd AACR-Bruce F. Cain Memorial Award.
• Martin J. Blaser, M.D., chairman of the department of medicine at New York University School of Medicine, received the 12th AACR-American Cancer Society Award for Research Excellence in Cancer Epidemiology and Prevention.
• David S. Alberts, M.D., director of Cancer Prevention and Control at the University of Arizona Cancer Center, Tucson, received the 8th AACR-Joseph H. Burchenal Clinical Cancer Research Award.
• Graham A. Colditz, M.D., Dr.P.H., of the Harvard Medical School, Harvard School of Public Health, and Dana-Farber Cancer Institute in Boston, had been scheduled to deliver the 8th AACR-DeWitt S. Goodman Memorial Lecture.
• Janet D. Rowley, M.D., D.Sc., of the University of Chicago Medical Center, had been scheduled to deliver the 6th AACR-Women in Cancer Research Charlotte Friend Memorial Lecture.
▪ In addition, AACR selected 15 investigators to receive the 2003 research awards.
• Manuel Perucho, Ph.D., director of the Oncogene and Suppressor Gene Program at the Burnham Institute in La Jolla, Calif., received the AACR-National Foundation for Cancer Research Professorship in Basic Cancer Research.
• Yi Zhang, Ph.D., of the University of North Carolina School of Medicine and Lineberger Comprehensive Cancer Center in Chapel Hill, received the AACR-Gertrude B. Elion Cancer Research Award.
• C. Max Schmidt, M.D., Ph.D., of the Indiana University School of Medicine in Indianapolis, and David A. Tuveson, M.D., Ph.D., of the University of Pennsylvania School of Medicine in Philadelphia, were awarded the AACR-PanCAN Career Development Award in Pancreatic Cancer Research.
• The AACR-Cancer Research and Prevention Foundation Career Development Award in Translational Lung Cancer Research was presented to Gabriela Chiosis, Ph.D., of the Memorial Sloan-Kettering Cancer Center in New York.
• Katherine L. Pogue-Geile, Ph.D., of the University of Pittsburgh, received the AACR-Pennsylvania Department of Health Services Career Development Award in Cancer Research.
• Andrew J. Li, M.D., of the Cedars-Sinai Medical Center and David Geffen School of Medicine at the University of California, Los Angeles, received the AACR-California Department of Health Services Career Development Award in Ovarian Cancer Research.
• Anjali Jain, Ph.D., of the Cedars-Sinai Prostate Cancer Center and UCLA, received the AACR-California Department of Health Services Career Development Award in Prostate Cancer Research.
• Alice E. Guardino, M.D., Ph.D., of Stanford University, and John V. Heymach, M.D., Ph.D., of the Children’s Hospital and the Dana-Farber Cancer Institute in Boston, were awarded the AACR-Amgen, Inc. Fellowships in Clinical or Translational Cancer Research.
• Geneviève Rodier, Ph.D., of the Institut de Recherches Cliniques de Montréal in Quebec, received the AACR-Anna D. Barker Fellowship in Basic Cancer Research.
• David Z. Chang, M.D., Ph.D., of the Memorial Sloan-Kettering Cancer Center in New York, received the AACR-Bristol-Myers Squibb Oncology Fellowship in Clinical Cancer Research.
• Cameron N. Johnstone, Ph.D., of the University of Pennsylvania in Philadelphia, was awarded the AACR-Pennsylvania Department of Health Fellowship in Cancer Research.
• Zhongxing Liang, M.D., Ph.D., of Emory University in Atlanta, was awarded the AACR-Cancer Research and Prevention Foundation Fellowship in Cancer Prevention Research.
• Patrick C. Ma, M.D., of the Dana-Farber Cancer Institute in Boston, was awarded the AACR-Cancer Research and Prevention Foundation Fellowship in Translational Lung Cancer Research.
▪ Gabriel Hortobagyi, M.D., professor of medicine and chair of the University of Texas M. D. Cancer Center’s Department of Breast Medical Oncology, Houston, has been awarded the 2003 Horizon Achievement Award in Cancer Research by Bristol-Myers Squibb Oncology and the Susan G. Komen Breast Cancer Foundation.
In his earlier work, Hortobagyi developed combined modality therapy for advanced breast tumors. He has also established a role for bisphosphonates in the management of patients with bone metastases.
▪ Merrill J. Egorin, Ph.D., co-director of the molecular therapeutics/drug discovery program at the University of Pittsburgh Cancer Institute, has received the Elliott Osserman Award for Distinguished Service in Support of Cancer Research. The award was given by the Israel Cancer Research Fund and recognizes Egorin’s service on the organization’s scientific review panel.